Clinical trials: Diabetes Mellitus Risk
Fitness Trackers, Physical Activity
Full-scale Intervention Study: Genetic Risk Communication and Wearables
Background: Communication of information about risk of type 2 diabetes (T2D) alone has not been associated with changes in habitual behaviors among individuals of European ancestry.
- Conditions
- Fitness Trackers, Physical Activity, Exercise, Genetic Predisposition to Disease
- Trial name
- NCT05524909
- Testing
- Genetic Risk Estimate, Genetic Risk Estimate + Fitbit Functions
- Where
- Hong Kong
- Volunteers
- 355 people, healthy volunteers welcome
- Sponsor
- The University of Hong Kong
Hypertension, Dyslipidemia
Nutrition and Exercise Intervention Study
The purpose of the present study was to clarify the effects of increase in physical activity on incidence and surrogate marker of cardiovascular diseases.
- Conditions
- Hypertension, Dyslipidemia, Diabetes, Low Back Pain
- Trial name
- NEXIS (NCT00926744)
- Testing
- physical activity
- Where
- Japan
- Volunteers
- 1,085 people, healthy volunteers welcome
- Sponsor
- National Institute of Health and Nutrition
Diabetes Mellitus, Type 2
Native Hawaiian Diabetes Intervention Program
The Native Hawaiian Diabetes Intervention Program is a project focused on determining whether a cultural-based, healthy lifestyles program with family support will have a positive effect on lifestyle behaviors and psychosocial…
- Trial name
- NCT00006165
- Testing
- 'Ohana (Family) Support Lifestyle Intervention
- Where
- United States
- Volunteers
- healthy volunteers welcome
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Neuropathy, Diabetic, Small Nerve Fiber Neuropathy
Characterization and Prediction of Early Onset Diabetic Peripheral Neuropathy
Predicting early onset neuropathy in people with type 1 diabetes
- Conditions
- Neuropathy, Diabetic, Small Nerve Fiber Neuropathy, Type 1 Diabetes
- Trial name
- NeuroPredict (NCT05546138)
- Testing
- Skin biopsies with quantification of intra-epidermal nerve fibre density, Perception Threshold Tracking, Thermal perception thresholds
- Where
- Denmark
- Volunteers
- 200 people
- Sponsor
- Aalborg University Hospital
High Risk Proliferative Diabetic Retinopathy, Diabetes Mellitus Type I
Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR.
To evaluate the safety and determine the efficacy of PRP monotherapy or combination therapy (pegaptanib 0.3 mg plus PRP) in patients with Type I or Type II diabetes mellitus and with high risk proliferative diabetic retinopathy.
- Conditions
- High Risk Proliferative Diabetic Retinopathy, Diabetes Mellitus Type I, Diabetes Mellitus Type II
- Trial name
- NCT01281098
- Testing
- Panretinal Photocoagulation (PRP), Intravitreous injection of pegaptanib
- Where
- Portugal
- Volunteers
- 22 people
- Sponsor
- Association for Innovation and Biomedical Research on Light and Image
HIV Infections, Diabetes
Yoga for Treating People at Risk for Diabetes or With Both HIV and Depression
The purpose of this study is to plan and develop an international collaboration for research on the health effects of yoga. This study will also determine the effects of yoga on people who are at an increased risk for developing…
- Conditions
- HIV Infections, Diabetes, Depression
- Trial name
- NCT00090506
- Testing
- Yoga
- Where
- India
- Volunteers
- 50 people
- Sponsor
- National Center for Complementary and Integrative Health (NCCIH)
Menopause, Perimenopausal Disorder
Virtual perI-/Menopause Registry of AusTrALia
13 million (50.7%) Australians are born with ovaries, 14% (~3 million) are currently aged 40-59 yrs, \& all such who live to midlife will experience menopause, defined as >12 months without a period.
- Conditions
- Menopause, Perimenopausal Disorder, Postmenopausal Symptoms, Health Knowledge, Attitudes, Practice
- Trial name
- VITAL (NCT06487130)
- Testing
- N/A Observational Registry
- Where
- Australia
- Volunteers
- 10,000 people, healthy volunteers welcome
- Sponsor
- Bespoke Clinical Research
Gestational Diabetes Mellitus, Pregnancy
Gestational Diabetes Mellitus and Cardiovascular Disease: The Role of Vascular Dysfunction
The purpose of this research study is to look at whether there are differences in blood vessel function, risk for developing diabetes (high blood sugar), lipid (blood fat) levels, and levels of other blood markers between black…
- Trial name
- NCT00998712
- Where
- United States
- Volunteers
- 88 people, healthy volunteers welcome
- Sponsor
- Brigham and Women's Hospital
Diabetes Mellitus, Type 2, Cardiovascular Diseases
A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease
The primary purpose of study is to estimate the incidence and comparative effect on health outcomes: 1) hospitalization for heart failure, 2) below knee lower extremity amputation.
- Trial name
- NCT03492580
- Testing
- Canagliflozin, Empagliflozin, Dapagliflozin
- Where
- United States
- Volunteers
- 714,582 people
- Sponsor
- Janssen Research & Development, LLC
Childhood Cancer Survivors Treated With Abdominal Radiation
Assessing Insulin Sensitivity and Diabetes Risk in Childhood Cancer Survivors Treated With Abdominal Irradiation
The purpose of this study is to better understand the risk factors and causes of diabetes in people who received radiation to the abdomen as children.
- Trial name
- NCT02248779
- Where
- United States
- Volunteers
- 42 people
- Sponsor
- Memorial Sloan Kettering Cancer Center
Type 2 Diabetes
The Dietary Guidelines 3 Diets Study
The goal of this project is to use a two-stepped study to examine both the adoption of the three dietary patterns as presented by the United States Dietary Guidelines (USDG) and testing of a refined, culturally tailored one-year…
- Trial name
- DG3D (NCT04981847)
- Testing
- Dietary Intervention Meetings
- Where
- United States
- Volunteers
- 63 people, healthy volunteers welcome
- Sponsor
- University of South Carolina
At Risk for Type 2 Diabetes Mellitus, Pre Diabetes
Primary and Secondary Prevention of Type 2 Diabetes Mellitus in Clark County
This pilot and feasibility study aims to assess the effectiveness of a nutrition education intervention using the Cooking Matters for Adults Curriculum (SNAP-Ed).
- Trial name
- NCT06387797
- Testing
- Cooking Matters for Adults (CMA+), Cooking Matters for Adults (CMA)
- Where
- United States
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- University of Nevada, Las Vegas
Overweight, Obesity
Effect of Consuming Beans for One Month on Blood Lipids, Satiety, Intake Regulation and Body Weight
This project investigates the effect of regular consumption of commercially available processed white beans (5 cups per week) on food intake, body weight, blood pressure, satiety hormones and glycemic response over a 4-week…
- Conditions
- Overweight, Obesity, Metabolic Syndrome, Diabetes
- Trial name
- NCT00741923
- Testing
- navy beans added to regular diet
- Where
- Canada
- Volunteers
- 14 people
- Sponsor
- University of Toronto
Postmenopausal, Prediabetes
Glucose-Guided Eating Pilot
This is a single center, parallel-arm randomized controlled pilot study that aims to examine the feasibility and acceptability of the glucose-guided eating (GGE) mobile app and intervention in two populations at risk of chronic…
- Conditions
- Postmenopausal, Prediabetes, Adolescent and Young Adult (AYA) Cancer Survivors
- Trial name
- GET CHARGED (NCT05998460)
- Testing
- Glucose-Guided Eating with CGM, CGM only
- Volunteers
- 100 people
- Sponsor
- Georgetown University
Diabetic Retinopathy, Diabetic Macular Edema
A Comparison of Islet Cell Transplantation With Medical Therapy for the Treatment of Diabetic Eye Disease
Diabetic eye disease remains a major cause of visual loss for individuals with type 1 diabetes, despite currently available treatments.
- Trial name
- NCT00853424
- Testing
- islet cell transplant, Medical therapy
- Sponsor
- University of British Columbia
Diabetes Type 2, DKA
Diabetic Ketoacidosis From New SGLT2i: Can Genomics Estimate Risk
Sodium glucose co-transporter 2 (SGLT2) inhibitors have revolutionized care for people living with type 2 diabetes mellitus (T2DM).
- Conditions
- Diabetes Type 2, DKA, Diabetic Ketoacidosis
- Trial name
- DaNGER (NCT05402579)
- Testing
- Genomic analysis
- Where
- 2 sites in Canada
- Volunteers
- 63 people
- Sponsor
- Mount Sinai Hospital, Canada
Gestational Diabetes
Prevention of Gestational Diabetes
Gestational diabetes mellitus (GDM)is a major health problem growing prevalence of obesity the older age of pregnant women A randomized controlled trial in 54 pregnant voluntary women at high risk for GDM.
- Trial name
- NCT01130012
- Testing
- Lifestyle: diet and exercise, Close follow-up: reporting diaries of food and exercise
- Volunteers
- 440 people, healthy volunteers welcome
- Sponsor
- Kuopio University Hospital
Type 2 Diabetes, Insulin Resistance
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
This research study collects health-related information and blood samples to better understand how body composition, lifestyle habits, and diet influence meta-inflammatory monocytes (MiMos) in adolescents.
- Conditions
- Type 2 Diabetes, Insulin Resistance, Obesity, Metabolic Disease
- Trial name
- NCT06007404
- Where
- United States
- Volunteers
- 175 people, healthy volunteers welcome
- Sponsor
- University of Michigan
Heart Failure, Diabetes Mellitus, Type 2
Electronic Alerts for Heart Failure Prevention in Diabetes
Type 2 diabetes mellitus (T2DM) is an independent risk factor for heart failure (HF) and is associated with significant morbidity and mortality.
- Trial name
- NCT04791826
- Testing
- On-screen electronic alert
- Where
- United States
- Volunteers
- 1,524 people
- Sponsor
- University of Texas Southwestern Medical Center
Diabetes Mellitus, Type 2 Treated With Insulin
Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP-1 Analogue
The association of insulin degludec with liraglutide in the same device (IDegLira) is a potent but at the same time safe drug that reduces the risk of hypoglycemia when compared to a basal or basal-bolus insulin schedule.
- Trial name
- NCT05767255
- Testing
- insulin degludec + liraglutide, Insulin Glargine - Insulin Aspart
- Where
- Colombia
- Volunteers
- 66 people
- Sponsor
- Hospital Universitario San Ignacio
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.